Skip to main content

UBS Group AG

Position in RNTX — Rein Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in RNTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$59,706
+$58,375 QoQ
Shares Held
57,410
+5506.4% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 59 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. RNTX ranks #386 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RNTX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $59,706 57,410
2026-03-31 $1,331 1,024
2025-12-31 $11,038 9,516
2025-09-30 $95 83
2025-06-30 $21,981 15,701
2025-03-31 $5,274 2,980
2024-12-31 $16,677 7,251
2024-06-30 $8,711 3,145
2024-03-31 $616 93
2023-12-31 $6,537 2,144
2023-06-30 $2,429 1,357
2023-03-31 $124 100
2022-12-31 $7,849 3,312